Additionally, ERO1L was also observed upregulated in breast cancer, and knockdown of ERO1L abrogated in vivo tumor growth and reduced metastasis (Kutomi et al., 2013; Tanaka et al., 2015). The gene discussed is ERO1A; the disease is breast carcinoma.